Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Rosa David A, Chief Executive Officer. Officer active across 2 companies, notably Biotricity INC.. Cumulatively, 40 reports have been published. Split: 1 buy · 2 sells. Total volume traded: €109k. Activity tracked since 15 September 2021. The latest transaction was filed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Rosa David A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,239 shares@ US$1.451.1% of flowCommon StockSEC:0001540354-23-000013:0
25 of 40 declarations
About Rosa David A
Rosa David A is Director, President and Chief Executive Officer. He is associated with NEUROONE MEDICAL TECHNOLOGIES Corp and Biotricity INC., with 40 filings in total. Across the 40 sampled recent filings, the buy and sell amounts are EUR 45275 and EUR 63229, respectively, the covered period runs from 2021-09-29 to 2026-04-01, and the most frequent transaction nature indicated is Tax withholding.